Regional expression and functional characterization of the L-type Ca2+-channel in myocardium from patients with end-stage heart failure and in non-failing human hearts

Journal of Molecular and Cellular Cardiology

Volumn 31, Issue 1, 1999, Pages 283-296

  Schwinger, R H G ^a,c   Hoischen, S ^a   Reuter, H ^a   Hullin, R ^b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

Expression; Function; Human myocardium; L type Ca2+ channel

Indexed keywords

CALCIUM CHANNEL; CALCIUM ION; CALSEQUESTRIN; ISRADIPINE; MESSENGER RNA; NIFEDIPINE; PROTEIN SUBUNIT;

ADULT; ARTICLE; CALCIUM HOMEOSTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DISSOCIATION CONSTANT; FEMALE; GENE EXPRESSION; HEART ATRIUM; HEART CONTRACTION; HEART FAILURE; HEART PAPILLARY MUSCLE; HEART VENTRICLE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MALE; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARCOLEMMA;

EID: 0032991940     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1998.0869     Document Type: Article

References (45)

1. Beuckelmann DJ, Näbauer M, Erdmann E, 1992. Intracellular calcium handling in isolated ventricular myocytes from patients with terminal heart failure. Circulation 85:1046-1055.
2. i-transients in single ventricular myocytes isolated from terminally failing human myocardium. Bas Res Cardiol 87: 235-243.
3. i-transients in human myocytes. Bas Res Cardiol 92: 105-110.
4. Biel M, Hullin R, Freudner S, Singer D, Dascal N, Flockerzi V, Hofmann F, 1991. Tissue-specific expression of high voltage activated dihydropyridine-sensitive L-type calcium channels. Eur J Biochem 200: 81-88.
5. Chomczynski P, 1993. A reagent for single step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15: 532-537.
6. Feldman MD, Copelas L, Gwathmey JK, Phillips P, Warren SE, Schoen FJ, Grossman W, Morgan JP, 1987. Deficient production of cyclic AMP: Pharmacologic evidence of an important cause of contractile dysfunction in patients with end-stage heart failure. Circulation 75: 331-339.
7. Ferry DR, Kaumann AJ, 1987. Relationship between β-adrenoceptors and calcium channel in human ventricular myocardium. Br J Pharmacol 90: 447-457.
8. Finkel MS, Patterson RE, Roberts WC, Smith TD, Keiser HR, 1988. Calcium channel binding characteristics in the human heart. Am J Cardiol 62: 1281-1284.
9. 2+-antagonists (Iproveratril, D 600, Phenylamine) with highly potent inhibitory effects on excitation-contraction coupling in mammalian myocardium. Pflügers Arch 307: R25.
10. 2+ overload - A new principle in cardiac pathophysiology. In: Dhalla NS (Ed.). Recent Advances in Studies on Cardiac Structure and Metabolism. Baltimore, MD: University Park Press, 563-580.
11. 2+-exchanger in the failing human myocardium. Circulation 94: 992-1002.
12. Flockerzi V, Bosse E, Biel M, Hullin R, Hofmann F, 1991. High voltage activated calcium channels: Molecular composition and function. Eur Heart J 12: 95-98.
13. Glossmann H, Ferry DR, Goll A, Striessnig J, Schober M, 1985. Calcium channels: Basic properties as revealed by radioligand binding studies. J Cardiovasc Pharmacol 7 (Suppl. 6): S20-S30.
14. Gwathmey JK, Copelas L, Mackinnon R, Schoen FJ, Feldman MD, Grossman W, Morgan JP, 1987. Abnormal intracellular calcium handling in myocardium from patients with end-stage heart failure. Circ Res 61: 70-76.
15. Gwathmey JK, Slawsky MT, Hajjar RJ, Briggs GM, Morgan JP, 1990. Role of intracellular calcium handling in force-interval relationships of human ventricular myocardium. J Clin Invest 85: 1599-1613.
16. 2+) in intact human myocardium. Circulation 82: 1266-1278.
17. 2+ in intact and skinned trabeculae from control and myopathic human hearts. J Clin Invest 82: 1578-1584.
18. Hullin R, Singer-Lahat D, Freichel M, Biel M, Dascal N, Hofmann F, Flockerzi V, 1992. Calcium channel beta subunit heterogeneity: Functional expression of cloned cDNA from heart, aorta and brain. EMBO J 11: 885-890.
19. Hullin R, Biel M, Flockerzi V, Hofmann F, 1993. Tissue-specific expression of calcium channels. Trends Cardiovasc Med 3: 48-53.
20. Hullin R, Asmus F, Steinbeck G, 1997. Competitive RTPCR for studying gene expression in micro biopsies. Mol Cell Biochem 172: 89-95.
21. Kobayashi A, Yamashta T, Kaneko M, Nishiyama T, Hayashi H, Yamazaki N, 1987. Effects of verapamil on experimental cardiomyopathy in the bio 14.6 Syrian hamster. J Am Coll Cardiol 10: 1128-1138.
22. Laemmli UK, 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
23. Lowry OH, Rosenbrough NJ, Farr AL, Randall RJ, 1951. Protein measurements with the folin phenol reagent. J Biol Chem 193: 265-275.
24. Mayoux E, Callens-El Amrani F, Swynghedauw B, Charlemagne D, 1988. Adaptional process of the cardiac calcium channels to pressure overload: Biochemical and physiological properties of the dihydropyridine receptors in normal and hypertrophied rat hearts. Am J Physiol 12: 390-396.
25. 2+-ATPase gene expression in the human ventricle during endstage heart failure. J Clin Invest 85: 305-309.
26. Morgan JP, 1991. Abnormal intracellular modulation of calcium as a major cause of cardiac contractile dysfunction. N Engl J Med 325: 625-632.
27. Movsesian MA, Leveille C, Krall J, Coyler J, Wang JH, Cambell KP, 1990. Identification and characterization of proteins in sarcoplasmic reticulum from normal and failing left ventricles. J Mol Cell Cardiol 22: 1477-1485.
28. 2+-transporting ATPase, phospholamban, and calsequestrin levels in non-failing and failing human myocardium. Circulation 90: 653-657.
29. 2+-ATPase, phospholamban, and calsequestrin in terminally failing human myocardium. J Mol Med 76: 434-441.
30. Näbauer M, Callwaert G, Cleemann L, Morad M, 1989. Regulation of calcium release is gated by calcium current, not gating charge, in cardiac myocytes. Science 244: 800-803.
31. Rasmussen RP, Minobe W, Bristow MR, 1990. Calcium antagonist binding sites in failing and non-failing human ventricular myocardium. Biochem Pharmacol 39: 691-696.
32. Sainte Beuve C, Allen PD, Dambrin G, Rannou F, Marty I, Trouve P, Bors V, Pavie A, Gandgjbakch I, Charlemagne D, 1997. Cardiac calcium release channel (ryanodine receptor) in control and cardiomyopathic human hearts: mRNA and protein contents are differentially regulated. J Mol Cell Cardiol 29: 1237-1246.
33. Scatchard G, 1949. The attraction of proteins for small molecules and ions. Ann NY Acad Sci 660-672.
34. Schröder F, Handrock R, Beuckelmann DJ, Hirt S, Hullin R, Priebe L, Schwinger RHG, Weil J, Herzig S, 1998. Increased availability and open probability of single L-type calcium channels from failing compared with non-failing human ventricle. Circulation 98: 969-976.
35. 1-subunit of the L-type voltage dependent calcium channel from normal human heart. Proc Natl Acad Sci 90: 6228-6232.
36. Schwinger RHG, Böhm M, Erdmann E, 1990. Effectiveness of cardiac glycosides in human myocardium with and without "downregulated" β-adrenoceptors. J Cardiovasc Pharmacol 15: 692-697.
37. Schwinger RHG, Böhm M, Erdmann E, 1992. Inotropic and lusitropic dysfunction in myocardium from patients with dilated cardiomyopathy. Am Heart J 123: 116-128.
38. Schwinger RHG, Böhm M, Müller-Ehmsen J, Uhlmann R, Schmidt U, Stäblein A, Überfuhr P, Kreuzer E, Reichart B, Eissner HJ, Erdmann E, 1993a. Effect of inotropic stimulation on the negative force-frequency-relationship in the failing human heart. Circulation 88: 2267-2276.
39. Schwinger RHG, Böhm M, Koch A, Uhlmann R, Überfuhr P, Kreuzer E, Reichart B, Erdmann E, 1993b. Force-frequencey-relation in human atrial and ventricular myocardium. Mol Cell Biochem 119: 73-78.
40. 2+ ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with non-failing hearts. Circulation 92: 3220-3228.
41. Scott BT, Simmermann HKB, Collins JH, Nadal-Ginard B, Jones LR, 1988. Complete amino acid sequence of canine cardiac calsequestrin deduced by cDNA cloning. J Biol Chem 263: 8958-8964.
42. 2+-exchanger in endstage heart failure. Circulation 75: 443-453.
43. 2+-channel) and calsequestrin genes in the myocardium of patients with endstage heart failure. J Clin Invest 90: 927-935.
44. Tuana BS, Murphy BJ, 1990. Biochemical analysis of L-type calcium channels from skeletal and cardiac muscle. Can J Physiol Pharmacol 68: 1482-1488.
45. Wagner JA, Sax FL, Weisman HF, Porterfield J, Mcintosh C, Weisfeldt ML, Snyder SH, Epstein SE, 1989. Calcium-antagonist receptors in the atrial tissue of patients with hypertrophic cardiomyopathy. N Engl J Med 320: 755-761.